Author: Bauer Michael Möller Hans-Jürgen Schneider Edith
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.7, Iss.4, 2006-03, pp. : 421-427
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pfizer's dual-acting β2 agonists/muscarinic M3 antagonists
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. :
Antidepressant therapy with duloxetine appears to be superior to paroxetine
Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. :